CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout 

Positive
AI Analysis

Summary

Viatris announced the acquisition of Pacira for $1.65 billion to expand its presence in the non-opioid pain management space, responding to growing market interest in alternatives to opioid-based therapies.

Importance:7/10
Sentiment:
0.50
M&Aacquisitionnon-opioid painpain management
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 8, 2026 4:20 PM

Read Original